Philip Ma, PrognomiQ CEO

Prog­nomiQ rais­es $34M for lung can­cer test

Prog­nomiQ has raised an ad­di­tion­al $34 mil­lion in fund­ing as the com­pa­ny pre­pares to re­lease its blood-based pro­tein test for lung can­cer.

The com­pa­ny is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.